Page last updated: 2024-08-26

alpha-benzyl-n-methylphenethylamine and ketanserin

alpha-benzyl-n-methylphenethylamine has been researched along with ketanserin in 1 studies

*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]

*Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cadet, JL; Clark, CR; Fahn, S1

Other Studies

1 other study(ies) available for alpha-benzyl-n-methylphenethylamine and ketanserin

ArticleYear
Behavioral effects of alpha-benzyl-N-methylphenethylamine (ABNMP), a methamphetamine analog: inhibition by ketanserin and para-chlorophenylalanine (PCPA).
    Pharmacology, biochemistry, and behavior, 1988, Volume: 29, Issue:1

    Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Fenclonine; Ketanserin; Male; Methamphetamine; Rats; Rats, Inbred Strains; Reaction Time

1988